Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American … – PR Newswire (press release)

Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2011 American
PR Newswire (press release)
There can be no assurance that that the data presented during the 2011 American Academy of Allergy Asthma & Immunology (AAAAI) Annual Meeting regarding Cinryze is predictive of how Cinryze will perform in commercial usage.

and more »

View full post on asthma – Google News

Could Differences In Lung Defects Be Linked To Gender? – Medical News Today (press release)

Could Differences In Lung Defects Be Linked To Gender?
Medical News Today (press release)
Researchers from the University of Wisconsin have raised questions about whether differences in lung defects could be linked to gender in a study presented at the 2011 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI).
Asthma Associated with Increased Risk of Diabetes, Heart DiseaseHealthCanal.com
Severe Eczema Linked to Lasting Milk, Egg Allergy in KidsU.S. News & World Report
Revalesio To Present Research On The Anti-Inflammatory Effects Of RNS60 In AsthmaBiomed Middle East
KBOI –Shreveport Times –TopNews United States
all 23 news articles »

View full post on asthma – Google News

Extensive Survey Shines Spotlight on Severity of Asthma, Allergies and Impact … – Newswise (press release)

Extensive Survey Shines Spotlight on Severity of Asthma, Allergies and Impact
Newswise (press release)
Newswise — Washington, DC, March 17, 2011 – Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) released results of a first-of-its-kind survey detailing the impact of asthma and allergies on the people who cope with it every day.

and more »

View full post on asthma – Google News

Extensive Survey Shines Spotlight on Severity of Asthma, Allergies and Impact … – PR Newswire (press release)

Extensive Survey Shines Spotlight on Severity of Asthma, Allergies and Impact
PR Newswire (press release)
WASHINGTON, March 17, 2011 /PRNewswire-USNewswire/ — Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) released a first-of-its-kind survey detailing the impact of asthma and allergies on the people who cope with it every day.

and more »

View full post on asthma – Google News

A/C Filters 4 Less Aims To Spread Awareness About Indoor Air Pollution – Online PR News (press release)

A/C Filters 4 Less Aims To Spread Awareness About Indoor Air Pollution
Online PR News (press release)
The American College of Allergy, Asthma and Immunology stated that 50% of all illnesses are either caused or irritated by poor indoor air quality. In the US, an estimated 20.3 million American have asthma, including 6.3 million children.

and more »

View full post on asthma – Google News

New Certification Standard Announced for Feather and Down Filled Bedding – PR Newswire (press release)

New Certification Standard Announced for Feather and Down Filled Bedding
PR Newswire (press release)
WASHINGTON, March 15, 2011 /PRNewswire-USNewswire/ — The asthma & allergy friendly® Certification Program announced today that it has developed and adopted a certification standard and testing protocol for Feather and Down Filled Bedding.

and more »

View full post on asthma – Google News

Theron Pharmaceuticals to Present at the BIO-Europe Spring Conference on March … – Business Wire (press release)

Theron Pharmaceuticals to Present at the BIO-Europe Spring Conference on March
Business Wire (press release)
Dr. Zhang will provide a company overview and highlight Theron's lead COPD/asthma candidate, TRN-157, for which the company is actively seeking Biopharma partners on a global or regional basis to maximize its broad therapeutic potential in these

and more »

View full post on asthma – Google News

N30 Pharmaceuticals Announces Publication of S-Nitrosoglutathione Reductase … – Marketwire (press release)

N30 Pharmaceuticals Announces Publication of S-Nitrosoglutathione Reductase
Marketwire (press release)
The report focuses on the lead chemical series which generated N30 N6022, a first in class GSNOR inhibitor currently in Phase 1b/2a trials for the treatment of asthma. GSNOR breaks down S-nitrosoglutathione (GSNO), and as such is an important regulator

and more »

View full post on asthma – Google News

UK: Millions of patients set to benefit from a modern NHS – 7thSpace Interactive (press release)


Virgin Media Music

UK: Millions of patients set to benefit from a modern NHS
7thSpace Interactive (press release)
Almost one in three of the population have a long term condition – such as asthma, heart and lung disease, arthritis, hypertension and diabetes – and half of people over the age of 60 have one. They are the biggest users of the NHS accounting for
NHS 'must change to meet demands'The Press Association
REFORM 'WILL SAVE THE NHS'Express.co.uk

all 252 news articles »

View full post on asthma – Google News